About Yushan Ventures
Yushan Ventures is a venture capital firm founded in 2011. It is primarily based out of Taipei, Taiwan. As of Sep 2020, Yushan Ventures has invested in 23 companies. It primarily invests in Series B round in China based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Retail. Most recently it participated in the $***** Series D round of LinkDoc Overall, Yushan Ventures portfolio has seen 1 unicorn, 3 IPOs and 7 acquisitions including key companies like Twilio, StradVision and Caribou Biosciences. CICC Capital co-invest with Yushan Ventures, sharing a substantial percentage of its portfolio. Yushan Ventures has team of 9 people including 3 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B & Series D
Portfolio IPOs
Portfolio Unicorns
Yushan Ventures' List of Top Investments
Yushan Ventures has a portfolio of 23 companies, one of which is a Unicorn. Their most notable investments are in Aixing Biological Technology and LinkDoc.Their portfolio spans across United States, Austria, China and 3 more locations. They have invested in Enterprise Applications, High Tech, Retail and 13 other sectors, across stages such as Series B, Series D stages. Here is the list of top investments by Yushan Ventures:
1. Twilio
Cloud based omnichannel communication and customer engagement platform. The platform offers a telephony infrastructure web service in the cloud, allowing web developers to integrate phone calls, text messages, and IP voice communications into the web, mobile, and traditional phone applications. It provides customer data platform that allows users to collect data from different channels, and manage the customer journeys in real time. It caters its solution to industries such as reatil, finance, healthcare, and more.
Key facts about Twilio
- Founded Year: 2008
- Location: San Francisco (United States)
- Annual Revenue: $1B+ as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $240M
- Employee Count: 7,775 as on Jul 31, 2026
- Investors: T. Rowe Price, TrueBridge and 40 Others
- Latest Funding Round: Post IPO, Jul 31, 2021, $*****
- Highlight: Public
2. Ethereum
Blockchain-based public network for decentralized applications. It is a blockchain-based distributed computing platform and operating system featuring smart contract functionality. It provides a decentralized virtual machine, the Ethereum Virtual Machine (EVM), which can execute scripts using an international network of public nodes. It enables developers to build and deploy decentralized applications.
Key facts about Ethereum
- Founded Year: 2013
- Location: Toronto (Canada)
- Stage: Series B
- Employee Count: 989 as on Jul 31, 2026
- Investors: 2020 Ventures, 27th Street Capital and 109 Others
- Latest Funding Round: Series B, Oct 21, 2021, $*****
- Highlight: Editors' Pick
3. StradVision
Developer of AI-based perception software for autonomous driving and advanced systems. The company’s core technology is deep learning-based recognition software using data from camera sensors. This technology delivers accuracy across various platforms. The company offers front view, surround view, and multi-camera system solutions. These solutions support features from basic advanced driver-assistance systems to higher levels of autonomous driving and parking.
Key facts about StradVision
- Founded Year: 2014
- Location: Seoul (South Korea)
- Stage: Public
- Total Funding till date: $137M
- Employee Count: 199 as on Jul 31, 2026
- Investors: Pegasus Tech Ventures, Yushan Ventures and 16 Others
- Latest Funding Round: Series C, Aug 09, 2022, $*****
- Highlight: Public
4. ScanTrust
ScanTrust creates copy-proof QR codes for use by retailers. The solution can be placed on product packages and verified using a smartphone and helps manufacturers protect against counterfeit goods as well as aids consumers to determine whether a potential purchase is real or fake.
Key facts about ScanTrust
- Founded Year: 2014
- Location: Beijing (China)
- Stage: Series A
- Total Funding till date: $5.53M
- Employee Count: 40 as on Jul 31, 2026
- Investors: EuroUS Ventures, Yushan Ventures and 22 Others
- Latest Funding Round: Grant (prize money), Oct 05, 2022, $*****
- Highlight: Editors' Pick
Provider of cell therapies to treat cancer and hematologic conditions. It has developed technology-based solutions for cellular engineering and analysis based on CRISPR-Cas9 biology. It is applying its tools and technologies in markets such as therapeutics, agricultural biotechnology, biological research, and industrial biotechnology. It has developed CAR-T cell therapies for non-Hodgkin lymphoma and myeloid leukemia, and iPSC-derived CAR-NK cell therapies for solid tumors.
Key facts about Caribou Biosciences
- Founded Year: 2011
- Location: Berkeley (United States)
- Annual Revenue: $10M - $50M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $157M
- Employee Count: 130 as on Jul 31, 2026
- Investors: Hyperspeed, Maverick Ventures and 37 Others
- Latest Funding Round: Post IPO, Jun 29, 2023, $*****
- Highlight: Public
Yushan Ventures' Year-on-Year Investment Trends
Its most recent first time investment was in LinkDoc.Yushan Ventures' Investments by Stage
Yushan Ventures has made 1 investment in Series B stage and 1 investment in Series D stage with an average round size of $102M.Yushan Ventures' Investments by Sector
Yushan Ventures has a diverse portfolio, with companies operating in the Life Sciences, Artificial Intelligence - Industry Applications, Enterprise Applications, HealthTech and High Tech. Notably, it has invested in 21 Tech companies, 14 Enterprise (B2B) companies, 11 Software companies and at least 8 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Life Sciences | 2 |
Artificial Intelligence - Industry Applications | 1 |
Enterprise Applications | 1 |
HealthTech | 1 |
High Tech | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
Yushan Ventures' Investments by Geography
Yushan Ventures has made most investments in China (2).Yushan Ventures' recent investments
Yushan Ventures has not made any investment in 2026 so far.Here are the most recent investments by Yushan Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 07, 2020 | China | Series D | 1514 | ||
Apr 21, 2020 | China | Series B | 2137 | - |
Unicorns in Yushan Ventures' Portfolio
Yushan Ventures has 1 unicorn in its portfolio - LinkDoc. The most recent unicorn in their portfolio is LinkDoc which became a unicorn in 2018, 2 years before Yushan Ventures first invested in it.Here is a list of unicorns in Yushan Ventures' portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
46 | Provider of the oncology-focused database | 2014 | Haidian | Series D | yfo{pnw |
IPOs and Publicly Listed companies in Yushan Ventures' Portfolio
3 of Yushan Ventures' portfolio companies have become public. StradVision got listed on the Korea Exchange (KRX), in Jun 2026 at marketcap of $413M and Caribou Biosciences got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $907M.Here are Yushan Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 30, 2026 | - | - | 9134 | |
Jul 23, 2021 | - | - | 5634 | |
Jun 23, 2016 | - | - | 7483 |
Acquired companies in Yushan Ventures' Portfolio
7 companies from Yushan Ventures' portfolio have been acquired. The most recent acquisition was Zymergen in Jul 2022 by Ginkgo Bioworks for $*****.Here are Yushan Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 25, 2022 | - | - | 5219 | |
Sep 16, 2021 | - | - | 7747 | |
Apr 23, 2021 | - | - | 6065 | |
Oct 11, 2016 | - | - | 2618 | |
Mar 21, 2016 | - | - | 1844 |
Team profile of Yushan Ventures
Yushan Ventures has a team of 9 members including 3 Partners and 4 Venture Partners located in China, Taiwan and 1 more location. Yushan Ventures' team does not sit on the board of any company as of now.Here is a list of all team members in Yushan Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Shanghai | - | - | |
Partner | Taipei | - | ||
Partner | - | - | ||
Venture Partner | San Francisco | - | - | |
Venture Partner | - | - | ||
Venture Partner | - | - | - | |
Venture Partner | - | - | - |
Co-investors of Yushan Ventures
Over the past 6 years, 7 investors have co-invested in Yushan Ventures's portfolio companies. This includes funds and angels.
- Invested before Yushan Ventures: China Investment Corporation, CBC Capital and 3 others have invested in rounds before Yushan Ventures. There is 1 company where China Investment Corporation has invested before Yushan Ventures and 1 company where CBC Capital has invested before Yushan Ventures.
- Top Co-investors of Yushan Ventures: CICC Capital entered a company along with Yushan Ventures.
- Invested after Yushan Ventures: Alibaba Health (1 company) is the only investor which has invested in Yushan Ventures's portfolio after their investments.
Recent News related to Yushan Ventures
•
•
•
•
•
•
•
•
China Investment Corporation-backed LinkDoc bags $102m in Series D+ roundDeal Street Asia•Sep 07, 2020•LinkDoc, CICC, CBC Capital, Yushan Ventures and 6 others
•
